nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

14.04.2020 | COVID-19 | Review Zur Zeit gratis

The epidemiology and clinical information about COVID-19

verfasst von: Huipeng Ge, Xiufen Wang, Xiangning Yuan, Gong Xiao, Chengzhi Wang, Tianci Deng, Qiongjing Yuan, Xiangcheng Xiao

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

In December 2019, pneumonia of unknown cause occurred in Wuhan, Hubei Province, China. On 7 January 2020, a novel coronavirus, named as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was identified in the throat swab sample of one patient. The World Health Organization (WHO) announced the epidemic disease caused by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). Currently, COVID-19 has spread widely around the world, affecting more than seventy countries. China, with a huge burden of this disease, has taken strong measures to control the spread and improve the curative rate of COVID-19. In this review, we summarized the epidemiological characteristics, clinical features, diagnosis, treatment, and prognosis of COVID-19. A comprehensive understanding will help to control the disease.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 395:497–506CrossRef

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513CrossRef

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585

Zarocostas J (2020) What next for the coronavirus response? Lancet 395:401CrossRef

International Committee on Taxonomy of Virus. Naming the 2019 Coronavirus (2020) https://talk.ictvonline.org/. Accessed 2 Mar 2020

Notice of the National Health Commission of the People’s Republic of China on revising the english name of novel coronavirus pneumonia(2020) http://www.nhc.gov.cn/yzygj/s7653p/202002/33393aa53d984ccdb1053a52b6bef810.shtml. Accessed 29 Feb 2020 (in chinese)

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565–574CrossRef

de Wit E, van Doremalen N, Falzarano D, Munster VJ (2016) SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14:523–534CrossRef

Deng SQ, Peng HJ (2020) Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med 9:575. https://doi.org/10.3390/jcm9020575

10.

National Health Commission of the People’s Republic of China. Update on the outbreak of novel coronavirus pneumonia as of 24:00 on 3 March 2020(2020) http://www.nhc.gov.cn/xcs/yqfkdt/202003/7a5f57b3f1b94954b1fc25f81dacc874.shtml. Accessed 4 Mar 2020 (in chinese)

11.

Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418–423CrossRef

12.

Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P et al (2020) Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. https://doi.org/10.1016/j.chom.2020.02.001

13.

Paules CI, Marston HD, Fauci AS (2020) Coronavirus infections-more than just the common cold. JAMA. https://doi.org/10.1001/jama.2020.0757

14.

Ji W, Wang W, Zhao X, Zai J, Li X (2020) Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol 92:433–440CrossRef

15.

Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S (2020) Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 79:104212CrossRef

16.

Chen L, Liu W, Zhang Q, Xu K, Ye G, Wu W et al (2020) RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microb Infect 9:313–319CrossRef

17.

Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S et al (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infec 9:221–236CrossRef

18.

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J et al (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395:514–523CrossRef

19.

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG et al (2020) A new coronavirus associated with human respiratory disease in China. Nature. https://doi.org/10.1038/s41586-020-2008-3

20.

Morse JS, Lalonde T, Xu S, Liu WR (2020) Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. Chembiochem. https://doi.org/10.1002/cbic.202000047

21.

Gralinski LE, Menachery VD (2020) Return of the coronavirus: 2019-nCoV. Viruses 12:135. https://doi.org/10.3390/v12020135

22.

Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol. https://doi.org/10.1128/jvi.00127-20

23.

Chen Y, Guo Y, Pan Y, Zhao ZJ (2020) Structure analysis of the receptor binding of 2019-nCoV. Biochemi Bioph Rese Co. https://doi.org/10.1016/j.bbrc.2020.02.071

24.

Zhang C, Zheng W, Huang X, Bell EW, Zhou X, Zhang Y (2020) Protein structure and sequence re-analysis of 2019-nCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1. bioRxiv 2020

25.

Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y et al (2020) Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. https://doi.org/10.1038/s41423-020-0374-2

26.

Xu X, Chen P, Wang J, Feng J, Zhou H, Li X et al (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. https://doi.org/10.1007/s11427-020-1637-5

27.

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O et al (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (New York, NY). https://doi.org/10.1126/science.abb2507

28.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. https://doi.org/10.1038/s41586-020-2012-7

29.

Yan R, Zhang Y, Li Y, Xia L, Zhou Q (2020) Structure of dimeric full-length human ACE2 in complex with B0AT1. bioRxiv

30.

Yan R, Zhang Y, Guo Y, Xia L, Zhou Q (2020) Structural basis for the recognition of the 2019-nCoV by human ACE2. bioRxiv

31.

Jiang S, Du L, Shi Z (2020) An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infec 9:275–277CrossRef

32.

Phan T (2020) Novel coronavirus from discovery to clinical diagnostics. Infect Genet Evol 79:104211CrossRef

33.

Lam TTY, Shum MHH, Zhu HC, Tong YG, Ni XB, Liao YS et al (2020) Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China. bioRxiv

34.

Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ et al (2020) Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins. bioRxiv

35.

Liu P, Jiang JZ, Wan XF, Hua Y, Wang X, Hou F et al (2020) Are pangolins the intermediate host of the 2019 novel coronavirus (2019-nCoV) ? bioRxiv

36.

Cohen J (2020) Wuhan seafood market may not be source of novel virus spreading globally. Science. https://www.sciencemag.org/news/2020/01/wuhan-seafood-market-may-not-be-source-novel-virus-spreading-globally. Accessed 2 Mar 2020

37.

Swerdlow DL, Finelli L (2020) Preparation for possible sustained transmission of 2019 novel coronavirus: lessons from previous epidemics. JAMA. https://doi.org/10.1001/jama.2020.1960

38.

WHO (2020) Coronavirus disease 2019 (COVID-19) Situation Report – 43. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200303-sitrep-43-covid-19.pdf?sfvrsn=2c21c09c_2. Accessed 4 Mar 2020

39.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL et al (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ (Clin Res Ed) 368:m792

40.

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ et al (2020) Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. https://doi.org/10.1111/all.14238

41.

Guan Wj, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al (2020) Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. https://doi.org/10.1101/2020.02.06.20020974:2020.02.06.20020974

42.

Yang X, Yu Y, Xu J,Shu H, Xia J, Liu H et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. https://doi.org/10.1016/s2213-2600(20)30079-5

43.

Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C et al (2020) Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New Engl J Med. https://doi.org/10.1056/NEJMc2001468

44.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New Engl J Med. https://doi.org/10.1056/NEJMoa2001316

45.

Carlos WG, Dela Cruz CS, Cao B, Pasnick S, Jamil S (2020) Novel Wuhan (2019-nCoV) coronavirus. Am J Resp Crit Care 201:P7–p8CrossRef

46.

Wang FS, Zhang C (2020) What to do next to control the 2019-nCoV epidemic? Lancet 395:391–393CrossRef

47.

Chen J (2020) Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. https://doi.org/10.1016/j.micinf.2020.01.004

48.

Wang G, Jin X (2020) The progress of 2019 novel coronavirus event in China. J Med Virol. https://doi.org/10.1002/jmv.25705

49.

Huanqiu.com Zhong Nanshan’s team: Isolating virus from urine of the patient with novel coronavirus pneumonia (2020) https://china.huanqiu.com/article/9CaKrnKpwOu. Accesseed 2 March 2020 (in chinese)

50.

Riou J, Althaus CL (2020) Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill 25. https://doi.org/10.2807/1560-7917.ES.2020.25.4.2000058

51.

Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W et al (2020) Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 92:214–217CrossRef

52.

Wu JT, Leung K, Leung GM (2020) Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. https://doi.org/10.1016/s0140-6736(20)30260-9

53.

Liu Y, Gayle AA, Wilder-Smith A, Rocklov J (2020) The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. https://doi.org/10.1093/jtm/taaa021

54.

Tang B, Bragazzi NL, Li Q, Tang S, Xiao Y, Wu J (2020) An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model 5:248–255PubMedPubMedCentral

55.

Zumla A, Hui DS, Perlman S (2015) Middle East respiratory syndrome. Lancet (London, England) 386:995–1007CrossRef

56.

Omari AA, Rabaan AA, Salih S, Al-Tawfiq JA, Memish ZA (2019) MERS coronavirus outbreak: implications for emerging viral infections. Diagn Microbiol Infect Dis 93:265–285CrossRef

57.

Yeung ML, Yao Y, Jia L, Chan JF, Chan KH, Cheung KF et al (2016) MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol 1:16004CrossRef

58.

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H et al (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med. https://doi.org/10.1056/NEJMoa2001191

59.

Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X et al (2020) CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. https://doi.org/10.1148/radiol.2020200230:200230

60.

Pan F, Ye T, Sun P, Gui S, Liang B, Li L et al (2020) Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology. https://doi.org/10.1148/radiol.2020200370:200370

61.

Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T et al (2020) Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. https://doi.org/10.1007/s00330-020-06731-x

62.

Kanne JP (2020) Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology. https://doi.org/10.1148/radiol.2020200241:200241

63.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C et al (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. https://doi.org/10.1016/s2213-2600(20)30076-x

64.

Liu Q, Wang RS, Qu GQ, Wang YY, Liu P, Zhu YZ et al (2020) Xin xing guan zhuang bing du fei yan si wang shi ti xi tong jie pou da ti guan cha bao gao. J Forensic Med. https://doi.org/10.12116/j.issn.1004-5619.2020.01.00 (in chinese)

65.

WHO (2020) Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed 2 Mar 2020

66.

National Health Commission of the People's Republic of China. novel coronavirus pneumonia diagnosis and treatment program (6th trial version) (in Chinese) (2020) http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2.shtml. Accessed 2 Mar 2020 (in chinese)

67.

Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W et al (2020) Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. https://doi.org/10.1148/radiol.2020200642:200642

68.

National Health Commission of the People's Republic of China. novel coronavirus pneumonia diagnosis and treatment program (5th trial version) (in Chinese) (2020) http://www.nhc.gov.cn/xcs/zhengcwj/202002/d4b895337e19445f8d728fcaf1e3e13a.shtml. Accessed 2 Mar 2020 (in chinese)

69.

National Health Commission of the People's Republic of China. Update on the outbreak of novel coronavirus pneumonia as of 24:00 on 12 February 2020 (2020) http://www.nhc.gov.cn/xcs/yqtb/202002/26fb16805f024382bff1de80c918368f.shtml. Accessed 2 Mar 2020 (in chinese)

70.

Han W, Quan B, Guo Y, Zhang J, Lu Y, Feng G et al (2020) The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. J Med Virol. https://doi.org/10.1002/jmv.25711

71.

Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ et al (2020) Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 35:e79CrossRef

72.

Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V et al (2016) Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531:381–385CrossRef

73.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. https://doi.org/10.1038/s41422-020-0282-0

74.

Wang Z, Chen X, Lu Y, Chen F, Zhang W (2020) Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. https://doi.org/10.5582/bst.2020.01030

75.

Shang L, Zhao J, Hu Y, Du R, Cao B (2020) On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 395:683–684CrossRef

76.

Russell CD, Millar JE, Baillie JK (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet (London, England). https://doi.org/10.1016/s0140-6736(20)30317-2

77.

Maxmen A (2020) More than 80 clinical trials launch to test coronavirus treatments. Nature 578:347–348CrossRef

78.

ClinicalTrials.gov (2020) https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=&cntry=&state=&city=&dist=. Accessed 2 Mar 2020

79.

Tang N, Deng L, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. https://doi.org/10.1111/jth.14768

80.

Wang W, Tang J, Wei F (2020) Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol 92:441–447

Titel: The epidemiology and clinical information about COVID-19
verfasst von: Huipeng Ge
Xiufen Wang
Xiangning Yuan
Gong Xiao
Chengzhi Wang
Tianci Deng
Qiongjing Yuan
Xiangcheng Xiao
Publikationsdatum: 14.04.2020
Verlag: Springer Berlin Heidelberg
Schlagwort: COVID-19
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 6/2020
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-020-03874-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The epidemiology and clinical information about COVID-19

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2020

Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study

Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence

Rapid identification by MALDI-TOF/MS and antimicrobial disk diffusion susceptibility testing for positive blood cultures after a short incubation on the WASPLab

Comparison of clinical outcomes of influenza A and B at the 2017–2018 influenza season: a cohort study

Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland

Thirty years of CMV seroprevalence—a longitudinal analysis in a German university hospital

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Update Innere Medizin